The Business and Summary of Significant Accounting Policies (Tables)

9 Months Ended

Sep. 30, 2024

Accounting Policies [Abstract]

Schedule of Certain Assets Measured at Fair Value on a Recurring Basis

Below are tables that present information about certain assets measured at fair value on a recurring basis (in thousands):

	Fair Value Measurements
	September 30, 2024
	Total		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Cash equivalents
Money market funds	$	19,558	$	19,558	$	—	$	—
Total cash equivalents	19,558		19,558		—		—
Short-term investments
U.S. treasury securities	73,283		32,562		40,721		—
Commercial paper	10,213		—		10,213		—
Corporate bonds	29,089		—		29,089		—
Total short-term investments	112,585		32,562		80,023		—
Long-term investments
U.S. treasury securities	16,201		—		16,201		—
Total long-term investments	16,201		—		16,201		—
Total	$	148,344	$	52,120	$	96,224	$	—
	Fair Value Measurements
	December 31, 2023
	Total		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Cash equivalents
Money market funds	$	24,102	$	24,102	$	—	$	—
Total cash equivalents	24,102		24,102		—		—
Short-term investments
U.S. treasury securities	99,779		40,336		59,443		—
Commercial paper	44,319		—		44,319		—
Corporate bonds	11,076		—		11,076		—
Total short-term investments	155,174		40,336		114,838		—
Long-term investments
U.S. treasury securities	21,657		3,975		17,682		—
Total long-term investments	21,657		3,975		17,682		—
Total	$	200,933	$	68,413	$	132,520	$	—

Schedule of Accrued Liabilities

Accrued liabilities consisted of the following (in thousands):

	September 30, 2024		December 31, 2023
Accrued research and development expenses	$	9,889	$	7,623
Accrued compensation	4,774		5,123
Other accrued liabilities	2,241		2,846
Total accrued liabilities	$	16,904	$	15,592